Tabalumab (LY2127399), a humanized monoclonal antibody (IgG4 type) targeting B-cell activating factor (BAFF), exhibits neutralizing activity against both membrane-bound and soluble BAFF. This compound is relevant for research into autoimmune diseases, in
CAS Number:
[1143503-67-6]
* VAT and and shipping costs not included. Errors and price changes excepted
